Quantum Biopharma Ltd. (CVE:QNT) Director Donal Carroll Purchases 500 Shares of Stock
Quantum Biopharma Ltd. (CVE:QNT – Get Free Report) Director Donal Carroll bought 500 shares of Quantum Biopharma stock in a transaction on Monday, July 14th. The stock was purchased at an average price of C$29.22 per share, with a total value of C$14,608.00. Quantum Biopharma Price Performance Analyst Ratings Changes Separately, Singular Research upgraded shares […]
More Stories
Massive Alaska North Slope Gas Discovery Could Power US for Nearly 3 Years
By Naveen Athrappully Alaska’s North Slope region could contain 96 trillion cubic feet of undiscovered and technically recoverable natural gas...
UK Must Be Ready for War in 1,000 Days, Says British Defense Secretary
By Rachel Roberts British Defense Secretary Wes Streeting has said the country must be ready for war in 1,000 days,...
Trump Offers $1 Million to Anyone Who Reports Voter Fraud Leading to Conviction
By Jack Phillips President Donald Trump on Monday said that he would provide $1 million to people who can report...
Federal Judge Strikes Down New York Body Armor Ban
By Jack Phillips A federal judge this past week overturned New York state’s ban on the sale and purchase of...
Anthropic Files Blockbuster IPO
By Andrew Moran Anthropic, the company behind Claude, is set to make its long-awaited Wall Street debut as soon as...
How Inventory Allocation Across Multiple Warehouses Can Reduce Delivery Times and Costs
A shopper in Seattle orders a pair of running shoes. Whether that package arrives quickly and cheaply depends on a...